Skip to content

efficacy of adjunctive moxibustion in the treatment of Tuberculosis

efficacy of adjunctive moxibustion in the treatment of Tuberculosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201504001033387
Enrollment
180
Registered
2015-02-13
Start date
2012-08-20
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

moxibustion
TB Treatment

Sponsors

Moxafrica
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: -Diagnosis of TB was by sputum smear -If Patient has been on TB treatment; it is for not more than 2 weeks -Patient should consent to join the study if he/she is to join it. -Patient should have an attendant who may help him/her with the treatment.

Exclusion criteria

Exclusion criteria: -Patient is under the age of 18 years -Patient who were judged to be unable to understand the instructions (of what they are to do while in the study e.g. how to use moxa) -Patients intending to leave/change treatment center before their TB treatment duration ends -Patients who are unable to come on all follow up visits -History of Allergy to moxa/moxibustion -Diabetic patients were excluded -pregnant women -Coexistance of a Type of TB, or any other illnesses that require the participants to take steroids in addition to TB medicine -If TB was not diagnosed using sputum smears.

Design outcomes

Primary

MeasureTime frame
sputum conversion rates ( from positive to negative)

Secondary

MeasureTime frame
sputum conversion rates ( from positive to negative)

Countries

Uganda

Contacts

Public ContactMerlin Young
MrlnYoung@aol.com(0)121 421 3480

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026